CORTEZ MASTO STATEMENT ON WHITE HOUSE PLAN TO COMBAT XYLAZINE THREAT
July 12, 2023
July 12, 2023
WASHINGTON, July 12 -- Sen. Catherine Cortez Masto, D-Nevada, issued the following news release on July 11, 2023:
U.S. Senator Catherine Cortez Masto (D-Nev.) released the following statement applauding the White House's Fentanyl Adulterated or Associated with Xylazine Response Plan. Cortez Masto is leading the bipartisan bill to regulate xylazine similar to a Schedule III controlled drug while protecting access for veterinarians. Her Combating Illicit Xylazine Act has broad biparti . . .
U.S. Senator Catherine Cortez Masto (D-Nev.) released the following statement applauding the White House's Fentanyl Adulterated or Associated with Xylazine Response Plan. Cortez Masto is leading the bipartisan bill to regulate xylazine similar to a Schedule III controlled drug while protecting access for veterinarians. Her Combating Illicit Xylazine Act has broad biparti . . .